Eli Lilly agreed to acquire LimmaTech Biologics — a Swiss clinical-stage biotech company developing vaccines for the prevention of life-threatening diseases — for up to USD 780 m in cash, inclusive of an upfront payment and additional potential payments based upon the achievement of certain clinical and regulatory milestones. In connection with the deal, Homburger […]
Wenger Vieli advised the shareholders of Augenmobil in connection with the acquisition of a majority participation by Vista Augenpraxen & Kliniken. Founded in 2019, Augenmobil provides mobile eye examinations combined with telemedical diagnosis, focusing on ophthalmological
Schellenberg Wittmer advised the shareholders of OPAL Associates Holding on its sale to Opal Supply Chain. OPAL is an AutoID system integrator, offering end-to-end hardware, software, and service solutions for logistics automation and SAP integration.
Bär & Karrer advised Lonza Group, a globally active manufacturer of pharmaceutical, biotech and specialty ingredients, on the sale of its entire stake in MicroMacinazione — a Ticino-based contract manufacturer of micronization active ingredients for
Schellenberg Wittmer advised InterAlpen Partners and Hale Capital Partners, a consortium of US investors, as lead counsel in connection with their USD 25m investment in Acutronic Holding, a defense technology company supplying propulsion, simulation, and
908 Devices Inc. (NASDAQ: MASS) completed the acquisition of Swiss-based Nirlab SA for a combination of cash and stock, including earn-out consideration. In connection with the deal, Homburger advised the buyer, while Wenger Vieli represented the
Niederer Kraft Frey (NKF) advised Affidea on the acquisition of Die Berner Urologen. Through this acquisition, Affidea extends its integrated urology network — already comprising Uroviva centres in Zurich, Zug, Lucerne, and Solothurn — to the canton
Deal & transactions
Advestra with Patrimonium on financing for Landis+Gyr’s EMEA business acquisition
Advestra advised the Patrimonium Middle Market Debt Fund and its investment manager, Patrimonium Asset Management (Patrimonium) on the provision of the acquisition financing in connection with the acquisition of the EMEA business of Landis+Gyr
Niederer Kraft Frey (NKF) advised the buyers on all aspects of the acquisition (including the financing of the acquisition) of the OPAL Associates AG (OPAL) headquartered in Switzerland together with its subsidiaries in Germany and
Niederer Kraft Frey advised Balgrist Apotheke on the acquisition of the Minerva Pharmacy in Zurich from Schaller Apotheken, with a multidisciplinary team covering corporate, healthcare, and real estate matters.
